Search Results
Jun 02, 2026, 11:55 ET ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine
how many people with chronic migraine remain inadequately served despite the real advances of recent years," said Samer Narouze, MD, PhD, and Brian Grosberg, MD, national co-principal investigators of the RELIEV-CM2 study. "Completing pivotal enrollment in a rigorous, randomized study of this
More news about: ShiraTronics, Inc.
Jun 02, 2026, 11:36 ET La nueva guía española adaptada culturalmente para el manejo de los síntomas del cáncer de mama metastásico se estrena en asco 2026
personalizada que permite a las comunidades hispanas navegar por un diagnóstico de cáncer de mama con confianza", dijo la Dra. Estelamari Rodríguez, MD, MPH, Directora Asociada de Alcance Comunitario, Sylvester Comprehensive Cancer Center, Facultad de Medicina Miller de la Universidad de Miami."Con
More news about: Viver Health
Jun 02, 2026, 11:31 ET Advanced NanoTherapies obtient plus de 31 millions de dollars de série B pour proposer le premier ballon enrobé de deux médicament (paclitaxel et sirolimus) recouvert de nanoparticules pour le traitement vasculaire.
utilisant des nanoparticules fonctionnalisées, ce qui permet une rétention locale durable du médicament à des doses plus faibles », a déclaré Rishi Puri, MD, cardiologue interventionnel, Cleveland Clinic.Cette technologie, sous licence exclusive de la Cleveland Clinic, est conçue comme une plateforme
More news about: Advanced NanoTherapies
Jun 02, 2026, 10:24 ET Leading Probiotic Brand, Florastor® Expands into Skin Wellness with Digest + Skin Renew Probiotic
this new launch, Florastor is partnering with entrepreneur and reality TV star Lindsay Hubbard and board-certified dermatologist Dr. Marisa Garshick, MD, FAAD, to showcase how gut balance can influence skin health.BEDMINSTER, N.J., June
More news about: Florastor
Jun 02, 2026, 10:23 ET Stelexis BioSciences Announces Positive Phase 1 Data for Eganelisib in Relapsed/Refractory AML and Higher-Risk MDS in an Oral Presentation at ASCO 2026
disease-specific, functional, biological vulnerabilities and offer therapies that selectively target those biological vulnerabilities" said Manuel Aivado, MD, PhD, President and Chief Executive Officer of Stelexis BioSciences. "We believe that myeloid malignancies may find in PI3K-gamma an analog to HER2 in
More news about: Stelexis BioSciences, Inc.
Jun 02, 2026, 10:18 ET CHOP's Center for Fetal Diagnosis and Treatment Celebrates 30th Annual Fetal Family Reunion at Philadelphia Zoo
N. Scott Adzick, MD, Surgeon-In-Chief at CHOP and co-director of the CFDT. "It's incredibly special to witness this community grow stronger and larger each year. The reunion
More news about: Children's Hospital of Philadelphia
Jun 02, 2026, 10:14 ET Chaberton Energy Named to Inc.'s Best Workplaces List for 2nd Year
stayed focused on its values through a challenging year for the distributed energy industryROCKVILLE, Md., June 2, 2026 /PRNewswire/ -- For the second year in a row, Chaberton Energy has been named to Inc.'s Best Workplaces
More news about: Chaberton Energy
Jun 02, 2026, 10:04 ET Statue Exhibit Features Women Using STEM to Power Sports at FIFA Fan Festival™ Dallas
Golfer and Data Scientist (Redwood Shores, CA)Marcia Faustin, MD, Family and Sports Medicine Physician (Sacramento, CA)Martha Walters, Broadcast Audio Engineer (Hendersonville, TN)Monique S. Burton, MD, Pediatrician and Sports Medicine Physician (Seattle, WA)Nadia
More news about: Lyda Hill Philanthropies’ IF/THEN® Initiative
Jun 02, 2026, 10:02 ET Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026
being presented at EHA provide further support for the promising overall survival signal we saw in our Phase 3 SENTRY results," said Reshma Rangwala, MD, PhD, Chief Medical Officer and Head of Research of Karyopharm. "Collectively, this new analysis, when combined with our existing landmark analysis, provides
More news about: Karyopharm Therapeutics Inc.
Jun 02, 2026, 10:00 ET FlyteHealth Selected for CMS Health Tech Ecosystem Diabetes & Obesity Category
results of improved outcomes across measures of diabetes, obesity, and hypertension. That experience is unique to FlyteHealth," said Cheryl Pegus, MD, MPH, CEO of FlyteHealth. "Being included in the CMS Health Tech Ecosystem continues FlyteHealth's expansion in integrated cardio-kidney-metabolic
More news about: FlyteHealth
Jun 02, 2026, 09:57 ET Adventure Awaits! Urban Air Adventure Park to Open in Baltimore Area
Urban Air Signs Lease to Bring Family Fun and Thrills to Owings Mills, MarylandOWINGS MILLS, Md., June 2, 2026 /PRNewswire/ --
More news about: Urban Air Adventure Park
Jun 02, 2026, 09:42 ET Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
drugs simultaneously to the lesion site using functionalized nanoparticles, enabling sustained local drug retention at lower doses," said Rishi Puri, MD, interventional cardiologist, Cleveland Clinic.The technology is exclusively licensed from Cleveland Clinic and built as a drug-agnostic, fully
More news about: Advanced NanoTherapies
Jun 02, 2026, 09:42 ET Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
drugs simultaneously to the lesion site using functionalized nanoparticles, enabling sustained local drug retention at lower doses," said Rishi Puri, MD, interventional cardiologist, Cleveland Clinic.The technology is exclusively licensed from Cleveland Clinic and built as a drug-agnostic, fully
More news about: Advanced NanoTherapies
Jun 02, 2026, 09:30 ET Rider Jet Center to Host 20th Annual Aviation Education & Career Expo: Over $2 Million Dollars in Scholarships Awarded To Date
The November 6, 2026, Event Will Welcome over 65 Vendors, and 1,300 StudentsHAGERSTOWN, Md., June 2, 2026 /PRNewswire/ --
More news about: Rider Jet Center
Jun 02, 2026, 09:29 ET Blend Acquires In516ht, a Snowflake Elite Partner, Expanding Enterprise AI Capabilities Globally
COLUMBIA, Md., June 2, 2026 /PRNewswire/ -- Blend360, a global AI services firm, today announced its acquisition of In516ht, a Snowflake Elite Partner and leading data engineering consultancy headquartered in Ljubljana, Slovenia,
More news about: Blend360
Jun 02, 2026, 09:19 ET Blend Acquires In516ht, a Snowflake Elite Partner, Expanding Enterprise AI Capabilities Globally
COLUMBIA, Md., June 2, 2026 /PRNewswire/ -- Blend360, a global AI services firm, today announced its acquisition of In516ht, a Snowflake Elite Partner and leading data engineering consultancy headquartered in Ljubljana, Slovenia,
More news about: Blend360
Jun 02, 2026, 09:16 ET NameSilo Technologies Corp. Announces Q1 2026 Results
announce the financial results for the quarter ending March 31, 2026. The financial statements and related management's discussion and analysis ("MD&A") can be viewed on SEDAR+ at
More news about: NameSilo Technologies Corp.
Jun 02, 2026, 09:05 ET EnableComp to Co-Host Women's Revenue Cycle Leadership Reception During HFMA Annual Conference 2026
An evening reception for healthcare finance and revenue cycle leadersNATIONAL HARBOR, Md., June 2, 2026 /PRNewswire/ -- EnableComp®, a leader in Complex Revenue Cycle Management, will co-host a Women's
More news about: EnableComp
Jun 02, 2026, 09:05 ET UWorld Finance Adds AI-Powered Study Tool UAsk™ to CFA® Exam Prep Courses
strengthens our role as a complete, integrated CFA learning system by giving candidates reliable support exactly where they study," said Chandra S. Pemmasani, MD, founder and CEO of UWorld. "Whether a CFA candidate needs a quick explanation of a fixed income concept or a deeper discussion about derivatives, UAsk
More news about: UWorld, LLC
Jun 02, 2026, 09:04 ET Invizix, Formerly Geminii Health Selected as Finalist in American Diabetes Association 2026 Innovation Challenge
published in Cell Metabolism and has been recognized with the NIH Director's New Innovator Award. Invizix is led by Calvin Carter, PhD, and Sunny Huang, MD, PhD. Learn more at invizix.health.Forward-Looking StatementsThis press release contains forward-looking statements regarding Invizix's
More news about: Invizix
Jun 02, 2026, 09:02 ET HOPPR® AI Foundry Now Available in AWS Marketplace to Power Medical Imaging AI Development
protection."Making HOPPR® AI Foundry available through AWS Marketplace is a natural evolution of our platform strategy," said Khan Siddiqui, MD, co-founder and CEO of HOPPR. "We are meeting healthcare and life sciences customers where they already operate, inside AWS, and giving them the tools
More news about: HOPPR
Jun 02, 2026, 09:00 ET Health Foundation of South Florida to Host 2026 Black Health Summit Featuring National Medical Association President Dr. Roger A. Mitchell, Jr., MD
Florida. Panelists include Melissa P. Dunn, Commissioner, City of Lauderhill; Armen Henderson, MD, MBA, UM General Internal Medicine Faculty Member and Founder of Dade County Street Response; Katherine Chung-Bridges, MD, MPH, Health Choice Network; and Catherine Toms, President, Green Cars 4 Kids.Beyond
More news about: Health Foundation of South Florida
Jun 02, 2026, 09:00 ET Hannah Abrams, MD Named Recipient of 2026 Conquer Cancer-AccessHope Young Investigator Award for Work Advancing Evidence‑Based Cancer Care
announced the recipient of the 2026 Conquer Cancer-AccessHope Young Investigator Award (YIA) in Health Services Research and Care Delivery: Hannah Abrams, MD, a hematology-oncology fellow at Fred Hutch Cancer Center and the University of Washington in Seattle. The one‑year, $50,000 grant will support Dr. Abrams'
More news about: AccessHope
Jun 02, 2026, 09:00 ET Leukemia Research Foundation of Delaware Commits $1 million To Accelerate Pediatric Leukemia Research Through Blood Cancer United's Dare To Dream Project
AML."The Dare to Dream Project is focused on breaking down barriers that have slowed progress in childhood cancer research," said E. Anders Kolb, MD, president and chief executive officer of Blood Cancer United. "This remarkable commitment from the Leukemia Research Foundation of Delaware brings new
More news about: BLOOD CANCER UNITED, INC.
Jun 02, 2026, 08:59 ET Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology
highlight selinexor's differentiated mechanism of action and its potential to offer a complementary approach to JAK inhibition," said Reshma Rangwala, MD, PhD, Chief Medical Officer and Head of Research of Karyopharm. "Importantly, these findings reinforce the opportunity to target biological pathways beyond
More news about: Karyopharm Therapeutics Inc.